Filing Details

Accession Number:
0001140361-11-022415
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-04-18 15:45:34
Reporting Period:
2011-03-04
Filing Date:
2011-04-18
Accepted Time:
2011-04-18 15:45:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1296391 Tengion Inc TNGN Biological Products, (No Disgnostic Substances) (2836) 200214813
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1341125 Richard Kuntz C/O Tengion, Inc.
2900 Potshop Lane, Suite 100
East Norriton PA 19403
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock ($0.001 Par Value) Acquisiton 2011-03-04 2,473,500 $2.83 2,473,500 No 4 P Indirect (1)
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect (1)
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock ($0.001 Par Value) Common Stock Warrant (right to buy) Acquisiton 2011-03-04 1,855,125 $0.00 1,855,125 $2.88
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,855,125 No 4 P Indirect
Footnotes
  1. Dr. Kuntz is employed by Medtronic, Inc. as Senior Vice President and Chief Scientific, Clinical and Regulatory Officer. Pursuant to the Securities Purchase Agreement dated March 1, 2011, Medtronic, Inc. acquired 2,473,500 shares of common stock and warrants to purchase 1,855,125 shares of common stock. Dr. Kuntz disclaims beneficial ownership of the common stock and warrants held by Medtronic, Inc.
  2. Subject to any restrictions set forth in the Warrant Agreement, all or any part of the warrant may be exercisable by Medtronic, Inc. at any time and from time to time on or after the original issue date of March 4, 2011 and through and including 5:30 P.M., New York City time, on March 4, 2016. At 5:30 P.M., New York City time, on March 4, 2016, the portion of the warrant not exercised prior thereto shall be and become void and of no value and the warrant shall be terminated and no longer outstanding.